A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute to collectively unearth new, effective drug combinations for liver cancer.
The five-year grant – the first P01 grant ever awarded to Massey in its five-decade history – will initiate a four-pronged approach to better understand the biology of liver tumors and advanced treatment options for hepatocellular carcinoma, the most common form of liver cancer.
“There are no other large, grant-funded projects like this in the country for obesity-associated liver cancer; it has the potential to change the way the disease is treated,” said Devanand Sarkar, M.B.B.S., Ph.D., the principal investigator on the grant, as well as associate director of cancer research training and education coordination and member of the Cancer Biology research program at Massey…